4,200
Views
1
CrossRef citations to date
0
Altmetric
Oncology

Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China

, , , , , , , & ORCID Icon show all
Pages 701-709 | Received 01 Feb 2023, Accepted 24 Apr 2023, Published online: 21 May 2023